Search results
Showing results for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
World Malaria Day 2022
25 April 2022
Patient recruitment is on-track in the Oxford-led DeTACT trial of safe, effective drug combinations to prevent the spread of artemisinin and multi-drug resistant malaria in Africa.
Unique Oxford study of vascular disease reaches 20th anniversary
14 April 2022
The only project of its kind anywhere that studies patients with all types of acute vascular events – including strokes, heart attacks, aneurysms – in order to develop better diagnostic tests and treatments celebrates its 20th anniversary this month.
Protease inhibitors safer than thought for pregnant women with HIV
13 April 2022
University of Oxford researchers assessed evidence from 34 studies, involving over 57,000 pregnant women with HIV, and found that protease inhibitor-based antiretroviral therapies significantly increased the risk of babies being small or very small for their gestational age, but there were no other adverse pregnancy outcomes, compared to therapies without protease inhibitors.
Diagnostic test could offer new hope for ME/CFS patients
13 April 2022
Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) is a chronic condition without a diagnostic test and some 80 - 90% of patients remain un-diagnosed. A new paper published in Frontiers in Medicine outlines how having a diagnostic test could greatly help both patients and medics.
Introducing the Viral Vector Core Facility
11 April 2022
This month, we speak to Dr Claire Powers, manager of the Viral Vector Core Facility about the facilities capabilities, how you can access these facilities, and how the VVCF played a critical early role in the development of the Oxford/AZ vaccine.
Expansion of the Oxford Joint Research Office
8 April 2022
Oxford’s Joint Research Office (JRO) has expanded to include teams from Oxford Health (OH) NHS Foundation Trust and Oxford Brookes University (OBU), joining the clinical research support teams from the University of Oxford (OU) and Oxford University Hospitals (OUH) NHS Foundation Trust.
Fran Platt awarded 2023 Thudichum Medal
7 April 2022
Pharmacology Head of Department, Professor Fran Platt, has been announced as the winner of the 2023 Thudichum Medal, presented by the Biochemical Society.
MSD IT Committee seeking new members
7 April 2022
An unexpected role for the cell’s largest membrane network
7 April 2022
A new Klemm Lab-led paper has uncovered a new mechanism involving the endoplasmic reticulum that is critical to the organisation and position of the microtubule (MT) cytoskeleton, which ultimately dictates the shape and function of our body’s cells.
Oxford spin-out Optellum attains CE marking for its early lung cancer diagnosis AI technology
6 April 2022
The contribution of individual features on clinical imaging scans to the performance of the LCP-CNN cancer risk prediction model developed in Oxford was investigated.
Research staff representatives connect to shape research culture
6 April 2022
Representatives from across Medical Sciences Division departments came together in a workshop to strengthen the research staff community and discuss organisational cultures.
First-ever Evidence-Based Health Care Summer School to take place this summer
5 April 2022
Led by the Centre for Evidence-Based Medicine, and jointly run by the Department for Continuing Education, this summer school invites EBHC students, supervisors, consumers, and leading evidence-based experts into the surroundings of Kellogg College, University of Oxford. 4-20 July. Spanning three weeks this unique experience offers: EBHC modules; non-accredited short courses; a selection of workshops and EBMLive 2022.
Oxford University retains top spot for spinout generation in the UK
4 April 2022
Oxford University has been ranked first in the UK for turning academic research into spinout companies, according to a new report published today by data analyst firm Beauhurst.
New research suggests targeting blood vessels could be key to controlling fibrotic disease
1 April 2022
By studying blood vessels at single cell resolution, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) Professor Jagdeep Nanchahal and colleagues found that in Dupuytren’s disease, a fibrotic disorder of the hand, the vasculature is key to orchestrating the development of human fibrosis.
The glass half full man: Professor Chas Bountra and Oxford's innovative future
1 April 2022
Forget the TV clichés about Oxford – all punting and pass the port. The 925-year-old university is full of the most amazing people who are helping and benefiting the world, well beyond the quads and spires, says Professor Chas Bountra, the university’s Pro-Vice-Chancellor for Innovation. After the events of the last two years - and the COVID-19 vaccine [2.5 billion doses delivered and counting] - this most enthusiastic champion of Oxford maintains there can be no doubt, innovation is part and parcel of the historic university’s future. Who knows what is coming next, he says, expectantly.
AI helps to detect bone fractures to 92% accuracy
31 March 2022
Research from the Botnar Institute for Musculoskeletal Sciences shows that Artificial Intelligence (AI) is an effective tool for fracture detection that has potential to aid clinicians in busy emergency departments.
Defining the role of resident memory B cells in the fight against influenza
31 March 2022
Researchers at the Kennedy Institute of Rheumatology have used 3D and live-imaging to show how resident memory B cells boost antibodies to fight influenza.
No increased risk of brain tumours for mobile phone users, new study finds
30 March 2022
Longstanding fears that using mobile phones may increase the risk of developing a brain tumour have been reignited recently by the launch of 5G (fifth generation) mobile wireless technologies. Mobile phones emit radiofrequency waves which, if absorbed by tissues, can cause heating and damage.